ACRIN Protocol 6661 SUMMARY OF CHANGES
|
|
- Phyllis Fletcher
- 5 years ago
- Views:
Transcription
1 Page 1 of 4 ACRIN Protocol 6661 SUMMARY OF CHANGES Cover Page ACRIN Vascular and Interventional Chair, Gary Dorfman, M.D., and his contact information have been deleted. Including Amendment #1-7 has been changed to Including Amendments # IRB Approval and Informed Consent, Page 4 ACRIN Headquarters fax number has been changed to , Page 5 ACRIN Patient Registration fax number has been changed to Data Collection Submission, Page 9 The address for data submission has been updated. The change of address for ACRIN headquarters to 1818 Market Street, Suite 1600, Philadelphia, PA Image Submission, Page 9 The address for image submission has been updated to 1818 Market Street, Suite 1600, Philadelphia, PA , Page 10 In the 2 nd sentence, for ablations in proximity to a neurovascular bundle supplying an extremity or in the spine has been added and the sentence now reads, General endotracheal or laryngeal mask anesthesia will not be allowed for ablations in proximity to a neurovascular bundle supplying an extremity or in the spine, since sensorimotor testing must be performed. The following statement regarding use of general anesthesia has been added after the 2 nd sentence: However, general anesthesia may be performed at a site where the nerve injury is not of clinical concern, especially if it is requested by the study participant and/or determined it is in the best interest of the participant to use general anesthesia Tests and Observations, Page 13 In the table, under Laboratory, tumor marker and its footnote, c. If baseline tumor markers are out of the normal range, follow at 1 month and 3 months (e.g. CEA, PSA, CA19-9, CA-125). have been deleted Laboratory, Page 13 2 nd sentence, Tumor markers if out of normal range at baseline will be measured at one and three months. has been deleted. ACRIN 6661 October 27, 2004
2 Page 2 of Adverse Event Reporting, Page 14 In the 2 nd paragraph, the following sentence has been revised and now reads, The revised NCI Common Terminology Criteria Adverse Events (CTCAE) version 3.0 (7/03) must be used to score event severity. The CTCAE version 3.0 and the CTC search tool are available on the CTEP web page ( , Page 15 Room 6050 has been added to the address for the submission of the expedited AE reports. The NCI-CIP 24-hour telephone report contact number and the hours for recorder have been updated and now read, To make a telephone report, contact NCI-CIP at , available 24 hours a day (recorder after hours from 4:30 PM to 8:00 AM E.S.T.). 14.1, Page 21 In the 3 rd sentence, Biomedical Imaging Program (BIP) has been changed to Cancer Imaging Program (CIP). 14.2, Page 21 In the 1 st sentence, BDMC staff has been changed to ACRIN staff Source Documentation for Audit, Page 23 The table has been extensively revised and now reads: 14.7 Source Documentation for Audit Form Data Collection / Time of Submission Source Documentation A0 Registration (SC)- Eligibility checklist must be completed prior to web registration. I1 Initial Evaluation Also known as on study form (A0) At time of registration via the ACRIN web site. Due within two weeks of registration SC - Eligibility checklist completed signed and dated by RA or MD. and/or A0 - Completed, signed and dated by RA, after signed consent. Lab report(s) Pathology report(s) MRI /CT report(s)** Participant History and Physical (H &P) MPACS documented by the MD and/or a medication log Physician progress notes and I1 - Completed, signed and dated by RA or MD*** TF RFA Treatment Due post RFA procedure. RFA procedure report (radiology) Form and/or Procedure notes (signed and dated by MD/Nurse) and/or TF form - signed and dated by MD*** QP MPAC Results This form (QP), completed by the RA, records The MPACS form(s) completed by the Participant ACRIN 6661 October 27, 2004
3 Page 3 of 4 Form the MPAC results that are completed by the Participant. Only the QP gets submitted to ACRIN. The MPACS or pain scales stay at the site. are the source document(s) for the QP form(s). and QP form(s) completed, signed and dated by the RA. F1 Follow-Up Form Due: 5 days prior to RFA procedure 14 days post RFA procedure 1 month post RFA procedure 3 months post RFA procedure There are 3 scheduled follow-up periods. Participant is to complete the DP Patient Pain Medication Diary Worksheet x3 (daily for one week prior to RFA, and for two weeks after RFA) Lab report(s) MRI /CT report(s)** Participant History and Physical (H & P) Physician progress notes and/or Treatment notes (including any reported toxicities) DP completed signed and dated by the Participant. (3 pages) and F1 - Completed, signed and dated by the RA. Appendix I Sample Consent for Research Study, Page 27 The blood test that show tumor marker has been deleted in the What Is Involved in the Study? section. In the Radiofrequency Ablation Procedure table, (to include tumor markers if necessary) has been deleted from the 2 nd column for blood tests. Risks Associated with Radiofrequency Ablation Treatment, Page 28 The following statement If you and your doctor elect to use sedation (general anesthesia) with the procedure, the risks of using sedation will be reviewed with you in separate consent by the anesthesiologist. has been added to inform participant if GA is recommended and prescribed. Appendix IV Participating Institution List, Page 36 This section has been extensively revised and now reads: ACRIN 6661 October 27, 2004
4 American College of Radiology Imaging Network Page 4 of 4 Beth Israel -Deaconess Hospital S. Nahum Goldberg, M.D., Radiology Brown University Damian Dupuy, M.D., Radiology Thomas DePetrillo, M.D., Oncology Thomas Jefferson University Hospital Adam Zoga, M.D., Radiology Inova Fairfax Hospital Alain Drooz, M.D. Evanston Hospital Tony Farrell, M.D. University of South Alabama Brad Steffler, M.D Wake Forest University Hospital, Bowman Gray Campus Ronald Zagoria, M.D., Radiology William Blackstock, M.D., Radiation Oncology Leon Lenchik, M.D., Musculoskeletal Radiology Frank Torti, M.D., Medical Oncology William Ward, M.D., Orthopedic Surgery UC Davis John McGahan, M.D. Barnes Jewish Hospital Daniel Brown, M.D. University of Pennsylvania S. William Stavropoulous, M.D. MD Anderson Kamran Ahrar, M.D. University of Massachusetts Sri Shankar, M.D. University of Miami Venkataramu Krishnamurthy, M.D. University of Alabama Robert Lopez, M.D. St. Elizabeth s Health Center Richard Barr, M.D. Quantum Radiology Gregory Smith, M.D. ACRIN Protocol 6661 October 27, 2004
5 Summary of Changes ACRIN 6661: Phase II Study of Percutaneous Radiofrequency Ablation of Bone Metastasis Using CT Guidance #7 April 30, The chart has been changed to indicate that history/physical is also required pre-rfa, as well as 1 week, 1 month, and 3 months post-rfa. Appendix I: Sample Consent Under the heading Radiofrequency Ablation Procedure, in the last sentence before the table, the words chemotherapy or have been deleted. A new sentence has been added: You will be asked not to have chemotherapy for 14 days. Appendix II: Protocol-Specific Application A line has been added for the name of the Research Associate. Appendix III: Eligibility Checklist The original question # 22 has been moved to the end of the checklist, and the list has been renumbered accordingly. Appendix IV: Participating Institution List Emory has been deleted because it is no longer a participating site.
6 Summary of Changes ACRIN 6661: Phase II Study of Percutaneous Radiofrequency Ablation of Bone Metastasis Using CT Guidance #5 March 5, In the first sentence, the word if has been deleted In the first sentence, chemotherapy has been deleted. In order to clarify the policy on chemotherapy, we have changed the parenthetical sentence that follows to read, (Chemotherapy will not be allowed within 14 days prior to and within 14 days post RFA procedure) In the second paragraph, in the sentence beginning If after the first 4min, than has been changed to then. 9.2 The second sentence has been deleted. The third sentence has been reworded to read, There are three 100 mm-long lines printed for visual analogue self assessment scales measuring intensity of pain (VASPI), mood (VASMOOD) and pain relief (VASPR). In the sixth sentence: for 1 (no pain) has been changed to from 1 (no pain). The seventh sentence has been deleted. In the following sentence, in person has been changed to by the patient The History/Physical column of the table has been changed to reflect the fact that physicals are required only at baseline The first sentence formerly read, History, performance status, and MPAC will be obtained daily for 14 days, at one month, and three months. It now reads, MPAC will be obtained daily for 14 days post RFA, at one month, and three months. History and performance status will be obtained at 1 week, one month, and three months The end of this sentence, with the attribution (possibly, probably, definitely related) to the protocol treatment has been deleted and replaced by regardless of attribution and whether the event was expected or unexpected In the chart, the submission time for the QP form has been changed from 14 days prior to RFA procedure to 14 days post RFA procedure.
7 Appendix I: Sample Consent Under the heading Radiofrequency Ablation Procedure, in the last sentence of the second paragraph, with chemotherapy or radioisotopes has been inserted. Appendix III: Eligibility Checklist The checklist has been replaced with the updated checklist that follows: APPENDIX III ACRIN 6661 ELIGIBILITY CHECK (page 1 of 3) Case # (to be provided upon activation) The following questions will be asked at Study Registration: 1. Institutional person registering case (initials only) (Y) 2. Have all of the questions on the Eligibility Checklist been completed? (Y) (Y) 3. Is the patient eligible for this study? 4. Date the study-specific Consent Form was signed? (Must be prior to study entry) 5. Patient s Initials (Last, First) 6. Verifying Physician (Site PI) 7. Participant s ID number (Do NOT utilize a medical record number or radiology-assigned number) 8. Date of Birth (mm-dd-yyyy) 9. Ethnic category 1 Hispanic or Latino 2 Not Hispanic or Latino 9 Unknown 10. Race 1 American Indian or Alaskan Native 2 Asian 3 Black or African American (not Latino) 4 Native Hawaiian or other Pacific Islander 5 White 6 More than one race 9 Unknown 11. Gender 1 Male
8 2 Female 12. Patient s Country of Residence 1 United States 2 Canada 3 Other 4 Unknown ELIGIBILITY CHECK (page 2 of 3) 13. Zip Code (US residents) 14. Patient s Insurance Status 1 Private insurance 2 Medicare 3 Medicare and private insurance 4 Medicaid 5 Medicaid and Medicare 6 Military or Veterans Administration 7 Self-pay 8 No means of payment 9 Unknown/decline to answer 15. Will any component of the patient s care be given at a military or VA facility? 16. Calendar Base Date (mm-dd-yyyy) 17. Other country of residence, specify: 18. Treatment Start Date 19. Registration Date 20. Name of Medical Oncologist (Y) 21. Bony metastases with a maximum size of < 8cm (Y) 22. If spinal metastasis, is the vertebral body cortex between the mass and spinal cord/nerve roots intact? _(Y). 23.Documented metastatic bone disease from primary other than musculoskeletal malignancy, lymphoma or leukemia. (6-10) 24. Persistent intractable pain as measured by the VASPI pain score on a 0-10 scale. (Y) 25. Pain originates from a solitary site of bony metastatic disease.
9 (Y) 26. Radiofrequency treatment will be performed within 5 days of baseline evaluations. (Y) 27. Platelets are 70,000/ul. ELIGIBILITY CHECK (page 3 of 3) (N) 28. Previous or scheduled treatment of metastases with chemotherapy, external beam radiation, or radioisotopes within 30 days immediately prior to RFA treatment. (Chemotherapy will not be allowed until 14 days post procedure.) (N) 29. Treatment site involves weight bearing long bone of the lower extremity. (N) (N) 30. Patient has a pacemaker. 31. Impending fracture or metallic fixation at RFA site. (Y) 32. Baseline laboratory assessments as described in Section 11.0 performed within 14 days of the RFA. (Y) 33. Discontinuation of medications in compliance with Section (N) 34. Is the treatment site located in the cervical, thoracic or lumbar spine? Signature of person responsible for data: Signature of person entering data onto the web: Date form completed (mm-dd-yyyy):
10 ACRIN 6661 Phase II Study of Percutaneous Radiofrequency Ablation of Bone Metastasis Using CT Guidance Summary of Changes #3 April 3, 2002 Risk of including the ablation of vertebral metastases has been addressed in the ICF under Risks Associated With Radiofrequency Ablation Treatment with the inclusion of: There is the risk, that if the RF electrode is positioned within the spinal column to treat a tumor, heat from the procedure may cause nerve damage (causing numbness and/or weakness). Again however, image guidance will be used to ensure that the electrode is placed appropriately, avoiding the risk of nerve injury.
11 ACRIN 6661 Phase II Study of Percutaneous Radiofrequency Ablation of Bone Metastasis Using CT Guidance Summary of Changes #2 March 13, 2002 Eligibility Criteria: I. Spinal metastases has been removed. IV. The maximum size of bone metastasis has been changed to 8 cm. X. Spinal metastasis has been removed. Section 2.0: Fifth paragraph: Spinal RFA for metastatic disease can be safely performed in the presence of an intact vertebral body cortex because cortical bone acts as an insulator and cerebrospinal fluid pulsations as well as the basivertebral venous plexus act as heat sinks to the RF energy has been added. Section 4.1.4: Maximum size of bone metastasis has been changed from 5 to 8 cm. Section 4.2.8: Spinal metastasis has been amended to include Spinal metastases that do not have an intact cortex between the mass and the spinal canal and exiting nerve roots. Section 9.1.1: Or reasonable alternatives based on institutional preference has been added as part of sedation options. Second Sentence: or in the spine has been added. Second paragraph: In patients with spinal metastases the vertebral body cortex between the mass and the spinal canal and exiting nerve root must be intact. An intact cortex will help prevent thermal toxicity to the spinal cord and nerve roots. The site principal investigators will be responsible for determining eligibility based upon the initial CT or MRI examination. has been added. Fourth paragraph: 5 cm or smaller not involving the spine or weight bearing bones of the lower extremity will enable any radiologist who has performed image guided RFA to successfully achieve the ablation strategy set forth in the methodology has been deleted. 1
12 Fourth paragraph: 8cm or smaller, and treating spinal metastases that have an intact vertebral body cortex will allow the study to accrue patients who would typically present with poorly controlled pain. Excluding all spinal metastases and treating only smaller tumors would prevent adequate patient accrual because it is unusual for cancer patients to have poorly controlled pain relief with small tumors and many cancer patients have spinal metastases given this common site of spread given the presence of the hematopoetic marrow. Weight bearing bones of the lower extremity will not be treated due to the risk of pathological fracture. has been added. Section 13.1: Last sentence: Or may benefit from RFA instead of radiation therapy due to the presence of localized disease has been added. Appendix II: Investigator Credentials: With at least one with the Radionics device has been added. Number of RF Ablations Performed: List number of procedures for each device has been added. Number of Bone RF ablations Performed: List number of procedures for each device has been added. Application Submission: Designee has been changed from Irene Mahon to Robert Tew. Appendix III: 17. Non-spinal has been removed. Maximum size has been amended from 5 cm to 8cm. 18. If spinal metastasis is the vertebral body cortex between the mass and spinal cord/nerve roots intact? has been added, thus changing the numbering of the list. Content has not been altered. 2
13 Appendix IV: - Thomas Jefferson University Hospital. John Carrino, M.D. has been added. -UCLA Medical Center Steven Raman, M.D, has replaced Leanne Seeger, M.D. The following sites/participants have been included: UC Davis John McGahan, M.D. Barnes Jewish Hospital Daniel Brown, M.D. Emory University Bill Torres, M.D. 3
14 #1 SUMMARY OF CHANGES ACRIN Study 6661 February 6, 2002 The following changes are in effect: Eligibility: Changed from: Aspirin and nonsteriodal anti-inflammatory medications, antiplatelet medications, or warfarin must be discontinued at least 7 days prior to the procedure. Low molecular weight heparin preparations must be discontinued 24 hours prior to the procedure. To: Aspirin and nonsteroidal anti-inflammatory medications, antiplatelet medications, or warfarin must be discontinued prior to the procedure for a time period that is appropriate given the drug half life and the drugs known antiplatelet activity (e.g., aspirin for 7 days and ibuprofen 24 hours). Low molecular weight heparin preparations must be discontinued 24-hours prior to procedure : Changed from: Aspirin and nonsteriodal anti-inflammatory medications, antiplatelet medications, or warfarin must be discontinued at least 7 days prior to the procedure. Low molecular weight heparin preparations must be discontinued 24 hours prior to the procedure. To: Aspirin and nonsteroidal anti-inflammatory medications, antiplatelet medications, or warfarin must be discontinued prior to the procedure for a time period that is appropriate given the drug half life and the drugs known antiplatelet activity (e.g. aspirin for 7 days and ibuprofen 24 hours). Low molecular weight heparin preparations must be discontinued 24-hours prior to procedure.
PARTIAL PROTOCOL- CONTACT ACRIN PROTOCOL DEVELOPMENT AND REGULATORY COMPLIANCE FOR A COMPLETE PROTOCOL
AMERICAN COLLEGE OF RADIOLOGY IMAGING NETWORK ACRIN 6661 A PHASE I/II STUDY OF PERCUTANEOUS RADIOFREQUENCY ABLATION OF BONE METASTASES USING CT GUIDANCE PARTIAL PROTOCOL- CONTACT ACRIN PROTOCOL DEVELOPMENT
More informationSUMMARY OF CHANGES Amendment 5, Version Date: March 24, 2010 Broadcast: 4/6/10
Amendment 5, Version Date: March 24, 2010 Broadcast: 4/6/10 RTOG 0239, "A Phase II Study Of Accelerated High Dose Thoracic Irradiation With Concurrent Chemotherapy For Patients With Limited Small Cell
More informationSUMMARY OF CHANGES Amendment 6, Version Date: March 29, 2010 [Broadcast: April 8, 2010]
Amendment 6, Version Date: March 29, 2010 [Broadcast: April 8, 2010] RTOG 0233, "A Phase II Randomized Trial for Patients With Muscle-Invading Bladder Cancer Evaluating Transurethral Surgery and BID Irradiation
More informationPLACE LABEL HERE. ACRIN 6659 Registration/Eligibility Institution
A0 ACRIN 6659 Registration/Eligibility No Case No Instructions: For potential study participants, Part 2 must be completed before Part 1 If any of the answers, for Part 2, vary from the prompts provided
More information3.1.4 The phrase, and only focal nuclear, was clarified to and/or only focal nuclear.
For Protocol Amendment 3: RTOG 1221, Randomized Phase II Trial of Transoral Endoscopic Head And Neck Surgery followed by Risk-Based IMRT and Weekly Cisplatin versus IMRT and Weekly Cisplatin for HPV Negative
More informationFor Protocol Amendment 5 of: RTOG 0938, A Randomized Phase II Trial of Hypofractionated Radiotherapy For Favorable Risk Prostate Cancer
Section For Protocol Amendment 5 of: RTOG 0938, A Randomized Phase II Trial of Hypofractionated Radiotherapy For Favorable Risk Prostate Cancer NCI/Local Protocol #: RTOG-0938/RTOG 0938 NCI Protocol Version
More informationPage 1, column 2, entry for Lech Papiez: Line 2: Former was added in front of Medical Lines 4-7 of his entry were deleted.
For Amendment 7 to: RTOG 0813, Seamless Phase I/II Study of Stereotactic Lung Radiotherapy (SBRT) for Patients NCI/Local Protocol #: RTOG-0813/RTOG 0813 NCI Protocol Version Date: June 8, 2015 (Broadcast
More informationNCI/Local Protocol #: RTOG-0521/RTOG NCI Protocol Version Date: December 22, 2014 (Broadcast date: 2/2/2015)
For Protocol Amendment 7of RTOG 0521, A Phase III Protocol of Androgen Suppression (As) And 3DCRT/IMRT Vs. As And 3DCRT/IMRT Followed By Chemotherapy With Docetaxel And Prednisone For Localized, High-Risk
More informationNational Oncologic PET Registry (NOPR) F-18 Fluoride PET Case Report Forms
Form (NOPR) F-18 Fluoride PET Case Report Forms Version Date Patient Information Sheet 06/17/10 (Spanish translation available at: http://www.cancerpetregistry.org/pdf/patient_info_spanish.pdf) Interpreting
More informationNCI/Local Protocol #: RTOG-0522/RTOG NCI Protocol Version Date: January 26, 2016
For Amendment 10 to: RTOG 0522, A Randomized Phase III Trial of Concurrent Accelerated Radiation and Cisplatin Versus Concurrent Accelerated Radiation, Cisplatin, and Cetuximab (C225) [Followed by Surgery
More informationNavigating Alliance Protocols
Navigating Alliance Protocols Morgen Alexander-Young, MPH Alliance Central Protocol Operations Program Alliance Spring 2017 Group Meeting Alliance Protocol History Alliance for Clinical Trials in Oncology
More informationFor Protocol Amendment 3 of: NRG-BR001, A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases
For Protocol Amendment 3 of: NRG-BR001, A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases NCI/Local Protocol #: NRG-BR001/NRG BR001 NCI Protocol Version
More informationNCI Protocol Version Date: October 11, 2016 (Broadcast: November 7, 2016) The protocol version date was updated
For Protocol Amendment 8 to: RTOG 1106 / ACRIN 6697, Randomized Phase II trial of individualized Adaptive Radiotherapy Using During-Treatment FDG-PET/CT And Modern Technology in Locally Advanced Non-Small
More informationThis section was clarified to direct questions regarding eligibility to the study data manager.
For Protocol Amendment 8 to: RTOG 0839, Randomized Phase II Study of Pre-Operative Chemoradiotherapy +/- Panitumumab (IND #110152) Followed by Consolidation Chemotherapy in Potentially Operable Locally
More informationThe document history table was updated to include Amendment 6.
For Protocol Amendment #6 to: RTOG 0913, Phase I/II Trial of Concurrent RAD001 (Everolimus) With Temozolomide/Radiation Followed by Adjuvant RAD001/Temozolomide in Newly Diagnosed Glioblastoma NCI Protocol
More informationSUMMARY OF CHANGES Amendment 3: August 17, 2011 (Broadcast: August 25, 2011)
Amendment 3: August 17, 2011 (Broadcast: August 25, 2011) RTOG 0529, A Phase II Evaluation of Dose-Painted IMRT in Combination with 5-Fluorouracil and Mitomycin-C for Reduction of Acute Morbidity in Carcinoma
More informationALL PRINCIPAL INVESTIGATORS/NURSES/DATA MANAGERS RE: PROTOCOL GOG-0233 ACRIN 6671, REVISION # 9 & #10
TO: FROM: ALL PRINCIPAL INVESTIGATORS/NURSES/DATA MANAGERS LEAH MADDEN PROTOCOL SECTION DATE: JUNE 27, 2011 RE: PROTOCOL GOG-0233 ACRIN 6671, REVISION # 9 & #10 Protocol Title: Utility of Preoperative
More informationResearch Compliance and Quality Assurance Program (RCQA): Audit Checklist Subject Specific
Protocol Title / Code: Sponsor: PI Name: Auditor Name: Audit Date(s): Subject #: Key Dates: Date participant was identified: Date of Initial Consent: Date of Optional Consent: Date of Re-consent(s): Date
More informationPERCUTANEOUS FACET JOINT DENERVATION
Status Active Medical and Behavioral Health Policy Section: Surgery Policy Number: IV-95 Effective Date: 10/22/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members should
More information2009 Pain Coding Update and Pain Industry Business Trends
2009 Pain Coding Update and Pain Industry Business Trends Linda Van Horn, MBA June 13, 2009 2009 Pain Coding Update and Pain Industry Trends Agenda 2009 CPT Coding Updates Pay For Incentives ICD-10 American
More informationLUCAS CHIROPRACTIC 903 Howard St. Walla Walla WA PATIENT INTAKE - update
LUCAS CHIROPRACTIC 903 Howard St. Walla Walla WA 99362 PATIENT INTAKE - update Name Today s Date / / Date of Birth / / Address City State Zip Please check box for preferred communication means E-Mail Home
More informationUTERINE FIBROID EMBOLIZATION
INTERVENTIONAL RADIOLOGY PROTOCOLS UTERINE FIBROID EMBOLIZATION Interventional Radiology Tower Health Medical Group offers the option to treat uterine fibroids with fibroid embolization (UFE), an alternative
More informationNCI/Local Protocol #: RTOG-1005/RTOG NCI Protocol Version Date: July 31, 2014
For Protocol Amendment 4 to: RTOG 1005, A Phase III Trial of Accelerated Whole Breast Irradiation With Hypofractionation Plus Concurrent Boost Versus Standard Whole Breast Irradiation Plus Sequential Boost
More informationAward Number: W81XWH
Award Number: W81XWH-14-2-0193 TITLE: Prevention of Bone Loss after Acute SCI by Zoledronic Acid: Durability, Effect on Bone Strength, and Use of Biomarkers to Guide Therapy PRINCIPAL INVESTIGATOR: Thomas
More informationJuly 2018 Submission Formatting Information
July 2018 Submission Formatting Information General Formatting Information for Export Files All data export files must be in standard ASCII comma-delimited format, either CSV or text format. Each line
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: facet_joint_denervation 6/2009 4/2017 4/2018 4/2017 Description of Procedure or Service Facet joint denervation
More informationExiting Data Formatting Information
Exiting Data Formatting Information General Formatting Information for Export Files All data export files must be in standard ASCII comma-delimited format, either CSV or text format. Each line must be
More informationPersonal Information. Full Name: Address: Primary Phone: Yes No Provider Yes No. Alternate Phone: Yes No Provider Yes No
OFFICE USE ONLY: Date of Intake: ID#: Staff mbr: Personal Information Full Name: Address: _ Last First M.I. Street Address Apartment/Unit # City State Zip Code County Date of Birth: Age: Mobile phone?
More informationPDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sat, 24 Nov 2018 15:12:21 GMT) CTRI Number Last Modified On 22/10/2013 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
More informationClinical Trials: Questions and Answers
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Clinical Trials: Questions
More informationWELCOME TO AGEWELL MEDICAL ASSOCIATES
WELCOME TO AGEWELL MEDICAL ASSOCIATES We offer the following checklist and suggestions to help make your first visit as easy and pleasant as possible. What to bring with you: [ ] All of your medications
More informationNational Imaging Associates, Inc. Clinical guidelines FACET JOINT INJECTIONS, MEDIAL BRANCH BLOCKS, AND FACET JOINT RADIOFREQUENCY NEUROTOMY
National Imaging Associates, Inc. Clinical guidelines FACET JOINT INJECTIONS, MEDIAL BRANCH BLOCKS, AND FACET JOINT RADIOFREQUENCY NEUROTOMY CPT Codes: Refer to pages 5 and 6 LCD ID Number: L35936 J K
More informationUltrasound and Fluoroscopic Paravertebral Facet Joint Injections
Policy Number FAC06222011RP Ultrasound and Fluoroscopic Approved By UnitedHealthcare Medicare Committee Current Approval Date 06/25/2014 IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY This policy is applicable
More informationRadiofrequency Ablation (RFA) / Microwave Ablation (MWA) of Lung Tumors
Scan for mobile link. Radiofrequency Ablation (RFA) / Microwave Ablation (MWA) of Lung Tumors Radiofrequency ablation (RFA) and microwave ablation (MWA) are treatments that use image guidance to place
More informationCPT 2015: Save Your Practice By Shaping Up Your Spinal Procedure Reporting
2015 Physician Coding Survival Guide CHAPTER 10: NEUROSURGERY CPT 2015: Save Your Practice By Shaping Up Your Spinal Procedure Reporting Sacroplasty codes will now be inclusive of imaging guidance. You
More informationINJECTION PROCEDURES
INJECTION PROCEDURES GENERAL CONSIDERATIONS AND PREPARATION FOR THE INJECTION In general, injection procedures for the spine and some other parts of the body entail the use of live x- ray known as flouroscopy
More informationEnrollment Form: Pancreas
Tissue Source Site (TSS) Name: TSS Identifier: _ TSS Unique Patient #: Completed By: Completion Date (MM/DD/YYYY): Form Notes: An Enrollment Form should be completed for each TCGA qualified case upon qualification
More informationNashville HMIS Intake Template Use COC Funded Projects: HMIS Intake at Entry Template
HMIS Data Collection Template for Project ENTRY CoC Program This form can be used by all CoC-funded project types: Prevention, Street Outreach, Safe Haven, Transitional Housing, Rapid Re-housing, Permanent
More informationWelcome to Medina Family Chiropractic and Acupuncture!
Welcome to Medina Family Chiropractic and Acupuncture! Please fill out this form and return it to the front desk. Let us know if you have any questions! Personal information Date: First name: Middle name:
More informationCP80 Version: V01. Acute Oncology Management Service Date approved: 8 th May 2015 Date ratified: 1 st June 2015 Review date: 1 st June 2017
STANDARD OPERATING PROCEDURE (SOP) AND PATHWAY FOR THE MANAGEMENT OF PATIENTS WITH METASTATIC SPINAL CORD COMPRESSION (MSCC) WITHIN THE CHRISTIE (Refer to the Manchester Cancer Network MSCC Pathway flowchart)
More informationYoung Investigator Initiative for the Conduct of ACRIN Ancillary Research
Program Purpose ACRIN is pleased to announce an opportunity for junior faculty (assistant professors and instructors within the first seven years post-fellowship or post-training) to carry out an ancillary
More informationApproved for public release; distribution unlimited
Award Number: W81XWH-16-1-0763 TITLE: Increasing Bone Mass and Bone Strength in Individuals with Chronic Spinal Cord Injury: Maximizing Response to Therapy PRINCIPAL INVESTIGATOR: Thomas J. Schnitzer,
More informationDamian Dupuy, MD. Image Guided Intervention (IGI) Studies 10:25 11:05 AM
Damian Dupuy, MD Image Guided Intervention (IGI) Studies 10:25 11:05 AM Image Guided Intervention (IGI) Studies Damian E. Dupuy, M.D., FACR Professor of Diagnostic Imaging The Warren Alpert Medical School
More informationSection FQ [FACILITY STAFF QUESTIONNAIRE] Sequence: 40
NHATS Round Section FQ [FACILITY STAFF QUESTIONNAIRE] Sequence: 40 FQPRE FQPRE T ON FILE If CMS DODFLAG= (DECEASED), display CMS REPORTED {SP} WAS DECEASED. CONFIRM WITH FACILITY THAT THE SP IS ALIVE BEFORE
More informationPatient Case Records Review
Patient Case Records Review Debra Herzan, RN, BSN, OCN, CCRP Alliance for Clinical Trials in Oncology Audit Workshop - Alliance Group Meeting November 3, 2016 6 Categories l Informed Consent l Eligibility
More informationPertussis. West Virginia Electronic Disease Surveillance System
Pertussis Electronic Disease Surveillance System Division of Surveillance and Disease Control Infectious Disease Epidemiology Program : 304-558-5358 or 800-423-1271 in Fax: 304-558-8736 Investigation Information
More informationSchool Consultation Project Application
2018-2019 School Consultation Project Application The goal of the School Consultation Project is to help your school district increase its capacity to service students with autism spectrum disorders (ASD)
More informationTMIST: Frequently Asked Questions
TMIST: Frequently Asked Questions Key Topics for Site Investigators and Staff This document answers frequently asked questions about the Tomosynthesis Mammographic Imaging Screening Trial (TMIST/EA1151);
More informationMDS Intake Questions July 21, 2009
MDS Intake Questions July 21, 2009 Notes: The updated MDS Intake questions contain two options for assessing use of different tobacco types. The first (Option 1), which is included in the primary section
More informationCERVICAL PROCEDURES PHYSICIAN CODING
CERVICAL PROCEDURES PHYSICIAN CODING Anterior Cervical Discectomy with Interbody Fusion (ACDF) Anterior interbody fusion, with discectomy and decompression; cervical below C2 22551 first interspace 22552
More informationREPORTING POSTOPERATIVE PAIN PROCEDURES IN CONJUNCTION WITH ANESTHESIA
Committee of Origin: Economics (Approved by the ASA House of Delegates on October 17, 2007 and last updated on September 2, 2008) ASA has recently received reports of payers inappropriately bundling the
More informationRemoval of Total Knee Arthroplasty (TKA) from the Inpatient-Only List (IPO)
November 7, 2017 Subject: (CMS 1678 F-C) Summary of the Centers for Medicare and Medicaid Services Fiscal Year 2018 Outpatient Prospective Systems () and Ambulatory Surgery System (ASC) Final Rule with
More informationA Patient s Guide to Pain Management: Radiofrequency Ablation
A Patient s Guide to Pain Management: Radiofrequency Ablation 2350 Royal Boulevard Suite 200 Elgin, IL 60123 Phone: 847.931.5300 Fax: 847.931.9072 DISCLAIMER: The information in this booklet is compiled
More informationPolicy Specific Section:
Payment Policy Anesthesia Services Type: Payment Policy Policy Specific Section: Payment Original Policy Date: Effective Date: October 1, 2010 06-16-2014 Description Anesthesia services consist of the
More informationDecember 1 Child Count Formatting Information
December 1 Child Count Formatting Information General Formatting Information for Export Files All data export files must be in standard ASCII comma-delimited format, either CSV or text format. Each line
More informationNational Fee Analyzer. Charge data for evaluating fees nationally. Sample page. Power up your coding optum360coding.com
2019 National Fee Analyzer Charge data for evaluating fees nationally Power up your coding optum360coding.com Contents Introduction...1 Key to Proper Reimbursement... 1 The Medical Coding System... 1 What
More informationLive Educational Programs
Live Educational Programs 2014 Osteoporosis: Essentials of Densitometry, Diagnosis and Management - for Clinicians Osteoporosis: Essentials of Densitometry, Diagnosis and Management - for Technologists
More informationEGD Data Collection Form
Sociodemographic Information Type Zip Code Gender Height (in inches) Race Ethnicity Inpatient Outpatient Male Female Birth Date Weight (in pounds) American Indian (Native American) or Alaska Native Asian
More informationNEW PATIENT HEALTH HISTORY
Meeks and Zilberfarb Orthopedics 1101 Beacon Street. Brookline, MA 02246 40 Allied Drive, Dedham, MA 02026 Tel: 617-232-2663 Fax: 617-232-6342 Tel:781-326-1561 Fax:781-326-1562 Jeffrey L. Zilberfarb, MD
More informationRadiotherapy symptoms control in bone mets. Francesco Cellini GemelliART. Ernesto Maranzano,MD. Session 5: Symptoms management
Session 5: Symptoms management Radiotherapy symptoms control in bone mets Francesco Cellini GemelliART Ernesto Maranzano,MD Director of Oncology Department Chief of Radiation Oncology Centre S. Maria Hospital
More informationRespond to the following questions for all household members each adult and child. A separate form should be included for each household member.
HMIS Data Collection Template for Project ENTRY CoC Program This form can be used by all CoC-funded project types: Prevention, Street Outreach, Safe Haven, Transitional Housing, Rapid Re-housing, Permanent
More informationPRIMARY INSURANCE. Subscriber Name: Subscriber ID/Policy #: Relationship to Patient: Self Wife Husband Parent Other Assignment of Insurance Benefits
PATIENT INFORMATION FORM MRN: Appt Appt Time: Last Name: Social Security #: First Name: Mid. Initial: Date of Birth: Home Address: Age: Sex: Home Address 2: Home Phone #: City, State, Zip: Work Phone #:
More informationBrain Tumors. What is a brain tumor?
Scan for mobile link. Brain Tumors A brain tumor is a collection of abnormal cells that grows in or around the brain. It poses a risk to the healthy brain by either invading or destroying normal brain
More informationJuly 2019 Submission Formatting Information
July 2019 Submission Formatting Information General Formatting Information for Data Files All data files must be in standard ASCII comma-delimited format, either CSV or text format. Each line must be terminated
More informationPATIENT REGISTRATION FORM
PATIENT REGISTRATION FORM NAME: D.O.B AGE: SEX: STREET: CITY: STATE: ZIP: SS #: ETHNICITY: RACE: LANGUAGE: PHONE # TO LEAVE A PERSONAL MESSAGE: HOME PHONE #: WORK #: CELL #: E MAIL ADDRESS: EMERGENCY CONTACT:
More informationAlbany County Coordinated Entry Assessment version 12, 11/29/16
Referral Completed by: PRE-SCREENING INFORMATION FOR SHELTER REFERRAL 1. First Name Last Name Date/Time: Other names (including nicknames): 2. Has client previously completed an application for assistance
More informationCT myelogram. Information for patients Radiology
CT myelogram Information for patients Radiology page 2 of 8 Myelogram Why do you need a myelogram? Most people who have a suspected problem with the nerves in their neck or back can be investigated with
More informationSubject ID: I N D # # U A * Consent Date: Day Month Year
IND Study # Eligibility Checklist Pg 1 of 15 Instructions: Check the appropriate box for each Inclusion and Exclusion Criterion below. Each criterion must be marked and all protocol criteria have to be
More informationTuberculosis in Chicago 2006
Chicago Department of Public Health May 27 Communicable Disease Information Tuberculosis in Chicago 26 City of Chicago Richard M. Daley, Mayor Department of Public Health Terry Mason, MD, FACS Commissioner
More information1st Annual UCLA State-of-the-Art in Neuro-Oncology
1st Annual UCLA State-of-the-Art in Neuro-Oncology Part 2 Brain and Spine Metastases: A Comprehensive, Multidisciplinary Approach Saturday, December 12, 2015 NRB Auditorium Neuroscience Research Building
More informationElizabeth David 1, Sagi Kaduri 1, Albert Yee 2, Edward Chow 3, Arjun Sahgal 3, Stephanie Chan 3, Ramez Hanna 1. Original Article
Original Article Initial single center experience: radiofrequency ablation assisted vertebroplasty and osteoplasty using a bipolar device in the palliation of bone metastases Elizabeth David 1, Sagi Kaduri
More informationExpanding Your Continuum of Care Percutaneous Neurostimulation for the Treatment of Pain
Expanding Your Continuum of Care Percutaneous Neurostimulation for the Treatment of Pain Overview Page 2 BiowavePENS Expanding the Continuum of Care www.biowave.com 1-877-BIOWAVE How Biowave Works BiowavePENS
More informationFIRST NAME MI LAST NAME BIRTH DATE (MM/DD/YYYY) GENDER. Name of person previously tested and relationship:
REQUEST FOR GERMLINE BAP1TESTING Please provide the following information. We cannot perform your test without ALL of this information. PLEASE PRINT ALL ANSWERS PATIENT INFORMATION* FIRST NAME MI LAST
More informationCancer A Superficial Introduction
Cancer A Superficial Introduction Gabor Fichtinger, Queen s University Cancer some definitions Medical term: malignant neoplasm Class of diseases in which a group of cells display: uncontrolled growth
More informationFederation of State Boards of Physical Therapy Minimum Data Set Questionnaire
Federation of State Boards of Physical Therapy Minimum Data Set Questionnaire Purpose: Understanding the current United States Health Workforce enables Federal and State Governments and Health Professional
More informationNorth Carolina Inpatient Hospital Discharge Data - Data Dictionary FY 2016 Alphabetic List of Variables and Attributes Standard Research File
North Carolina Inpatient Hospital Discharge Data - Data Dictionary FY 2016 Alphabetic List of Variables and Attributes Standard Research File For a standard research file request one of three variables
More informationCD Horizon Spire. CD Horizon Spire Z PHYSICIAN REIMBURSEMENT REIMBURSEMENT GUIDE. Spinal System and. Spinal System
REIMBURSEMENT GUIDE CD Horizon Spire Spinal System and CD Horizon Spire Z Spinal System The CD Horizon Spire Plate is a posterior, single level, non-pedicle supplemental fixation device intended for use
More informationSection I Project Leader: Michael P. Catalino Credentials: MD, DO, MS. Male Female Date of birth: 6/24/1987 NC medical license no.
North Carolina Spine Society Tel: 919-833-3836 PO Box 27167 Fax: 919-833-2023 Raleigh, NC 27611 ncspine@ncmedsoc.org Section I Project Leader: Michael P. Catalino Credentials: MD, DO, MS Male Female Date
More informationWELCOME TO AGEWELL MEDICAL ASSOCIATES
WELCOME TO AGEWELL MEDICAL ASSOCIATES We offer the following checklist and suggestions to help make your first visit as easy and pleasant as possible. What to bring with you: [ ] All of your medications
More informationPatient Information. Account #: Date: Person Responsible For Payment (Other than patient):
Patient Information Account #: Date: Race: Ethnicity: Tobacco Use: White or Hispanic Asian Black or African American Native Hawaiian or Pacific Islander American Indian or Alaskan Native Hispanic or Latino
More informationSurgery Estimate of Usual & Customary Billed Charges
Surgery Estimate of Usual & Customary Billed Charges SAMPLE REPORT For more information or to order an estimate please contact: Mark Guilford m.guilford@accumedintel.com (303) 495-5191 Prepared For: Glenn
More informationCLINICAL GUIDELINES. Update Summary
CLINICAL GUIDELINES CDI Quality Institute Anticoagulation and Antiplatelet Guidelines for Patients Undergoing Percutaneous Image-Guided Needle Procedures: An Update Concerning Facet Joint Injections, Medial
More informationTREAT SPINAL METASTASES WITH REPRODUCIBLE PRECISION
TREAT SPINAL METASTASES WITH REPRODUCIBLE PRECISION OsteoCool RF Ablation System YOUR EXPERTISE OUR INNOVATION The OsteoCool RF Ablation System is cooled radiofrequency ablation technology. It offers simultaneous,
More informationNew Hampshire Continua of Care. PATH Street Outreach Program Entry Form for HMIS
Please refer to the 2014 HUD HMIS Data Standards Version 5.1, available on the NH-HMIS website: www.nh-hmis.org for an explanation of the data elements in this form. Date form completed: Outreach worker
More informationNew patients approved for the Novo Nordisk PAP may only be eligible for insulin vials. For a full list of available products, please visit:
The Novo Nordisk Diabetes Patient Assistance Program (PAP) provides medication to qualifying applicants at no charge. If the applicant qualifies under the Novo Nordisk Diabetes PAP guidelines, a 120-day
More informationa guide to Reimbursement of Intermittent Catheters Know your options M2116N 04.08
a guide to Reimbursement of Intermittent Catheters 1 Know your options Coloplast Corp. Minneapolis, MN 55411 1.800.533.0464 usmedweb@coloplast.com www.us.coloplast.com is a registered trademark of Coloplast
More informationHeartland Kidney Network Network Patient Representative (NPR) Application
920 Main Street, Suite 801 Kansas City, MO 64105 Main Telephone Number: 816/880-9990 Patient Only Toll-Free Telephone Number: 800/444-9965 Fax: 816/880-9088 Heartland Kidney Network Network Patient Representative
More informationInstitution INSTRUCTIONS (M3) - All other imaging studies, including CT, CONVENTIONAL MRI, PET SCINTIGRAPHY, etc... AND
M3 ACRIN 6660 Whole Body MRI in the Evaluation of Pediatric Malignancies Whole Body MRI Imaging Form No. Revised/corrected form, check box and fax to 215-717-0936 INSTRUCTIONS (M3) 1. This form is to be
More informationPOSTERIOR CERVICAL FUSION
AN INTRODUCTION TO PCF POSTERIOR CERVICAL FUSION This booklet provides general information on the Posterior Cervical Fusion (PCF) surgical procedure for you to discuss with your physician. It is not meant
More informationPATIENT REGISTRATION FORM
PATIENT REGISTRATION FORM (Please print clearly) Last Name MI First Name Date of Birth Home Address Mailing Address if different Home Phone Work Phone Other/Cell Phone EHR Certification Patient Information
More informationCost Analysis of Magnetically Controlled Growing Rods Compared with Traditional
Cost Analysis of Magnetically Controlled Growing Rods Compared with Traditional Growing Rods for Early Onset Scoliosis in the United States: An Integrated Healthcare Delivery System Perspective TECHNICAL
More informationBecome a Cardiovascular Administrator Member of the American College of Cardiology. One Membership. Many Benefits. ACC is Your Professional Home.
Become a Cardiovascular Administrator Member of the American College of Cardiology Optimize your practice. Connect with physicians. One Membership. Many Benefits. ACC is Your Professional Home. Connect
More informationExpand Your Continuum of Care Percutaneous Neurostimulation for Pain
Expand Your Continuum of Care Percutaneous Neurostimulation for Pain How BiowavePENS Works BiowavePENS delivers therapeutic electrical signals through a patented percutaneous electrode array to block pain
More informationFRAME CHIROPRACTIC South Price Road, Suite D-110 Tempe, Arizona Phone: Fax:
3330 South Price Road, Suite D-110 Tempe, Arizona 85282 Phone: 480.345.2080 Fax: 480.345.2199 W E L C O M E ABOUT YOU (please print) Today s Date: Patient Name: DOB: Age: SS#: Mailing Address: City: State:
More informationRegistration and History Form
Registration and History Form PATIENT INFORMATION Date: / / Patient Address City State Zip Sex M F Age Birthdate Occupation _ Employer Spouse s Name _ Sex M F Age Birthdate Occupation Spouse s Employer
More informationNATIONAL CERTIFICATE IN TOBACCO TREATMENT PRACTICE (NCTTP) APPLICATION
NATIONAL CERTIFICATE IN TOBACCO TREATMENT PRACTICE (NCTTP) APPLICATION I. Personal Information Name: Home Address: City: State/Province: _ Country: Zip Code: _ Work Address: City: State/Province: _ Country:
More informationPatient Price Information List January 1, 2018
In compliance with state law, Western Reserve Hospital is providing this price list containing our charges for Room and Board, Emergency Department, Operating Room, Physical Therapy, Pain Medicine and
More informationPOLICY AND PROCEDURE
PAGE: Page 1 of 8 SCOPE: This policy applies to any provider furnishing services represented by Category III CPT codes. PURPOSE & IMPORTANT REMINDER: This policy is current at the time of publication.
More informationChapter 4 Section 20.1
Surgery Chapter 4 Section 20.1 Issue Date: August 29, 1985 Authority: 32 CFR 199.4(c)(2) and (c)(3) Copyright: CPT only 2006 American Medical Association (or such other date of publication of CPT). All
More informationNVM5 NERVE MONITORING SYSTEM AN INTRODUCTION TO
AN INTRODUCTION TO NVM5 NERVE MONITORING SYSTEM This booklet is designed to inform you about the use of NVM5 nerve monitoring in the course of your surgery. It is not meant to replace any personal conversations
More information